US Stock MarketDetailed Quotes

Vor Biopharma (VOR)

Watchlist
  • 14.060
  • -0.710-4.81%
Close Jan 15 16:00 ET
544.41MMarket Cap-0.04P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Vor Biopharma (VOR) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-130.46%-53.66M
-61.05%-35.18M
-1.97%-31.07M
0.63%-99.66M
-0.15%-24.06M
16.54%-23.29M
9.35%-21.85M
-25.54%-30.47M
-17.79%-100.29M
-30.96%-24.03M
Net income from continuing operations
-2,848.89%-812.68M
-5,552.75%-1.57B
-5.46%-32.49M
0.81%-116.91M
-16.95%-30.71M
16.97%-27.56M
7.14%-27.84M
-8.34%-30.8M
-27.98%-117.86M
-9.83%-26.26M
Operating gains losses
--790.46M
--1.3B
--1K
---18K
----
----
----
----
----
----
Depreciation and amortization
-99.76%2K
134.41%2.04M
-12.51%825K
1.03%3.53M
-3.03%865K
-4.70%851K
-0.11%869K
12.66%943K
38.30%3.49M
41.14%892K
Other non cash items
-33,846.21%-44.55M
18,026.46%226.76M
6.33%1.31M
6.64%5.04M
-50.37%2.43M
105.33%132K
6.20%1.25M
8.17%1.23M
32.11%4.73M
407.05%4.89M
Change In working capital
5,208.08%5.06M
228.76%4.63M
35.97%-2.64M
-99.23%5K
461.49%2.82M
-107.81%-99K
68.02%1.41M
-508.57%-4.12M
106.61%650K
-871.29%-779K
-Change in prepaid assets
55.62%-75K
14,215.00%2.86M
67.46%-231K
-125.54%-835K
-96.63%24K
-149.13%-169K
-99.09%20K
-10,242.86%-710K
1,353.33%3.27M
882.42%712K
-Change in payables and accrued expense
931.13%5M
98.91%1.1M
44.68%-1.37M
-21.37%2.24M
2,043.60%3.69M
-81.76%485K
414.95%551K
-2,720.45%-2.48M
155.83%2.85M
-89.61%172K
-Change in other current assets
-72.60%151K
10.99%1.95M
300.00%14K
228.72%2.43M
117.77%129K
167.36%551K
468.13%1.76M
-105.22%-7K
-161.72%-1.89M
-1,444.68%-726K
-Change in other current liabilities
97.93%-20K
-39.17%-1.28M
-13.79%-1.05M
-6.89%-3.83M
-9.28%-1.02M
-5.34%-966K
8.01%-919K
-26.16%-921K
65.73%-3.58M
33.87%-937K
Cash from discontinued investing activities
Operating cash flow
-130.46%-53.66M
-61.05%-35.18M
-1.97%-31.07M
0.63%-99.66M
-0.15%-24.06M
16.54%-23.29M
9.35%-21.85M
-25.54%-30.47M
-17.79%-100.29M
-30.96%-24.03M
Investing cash flow
Cash flow from continuing investing activities
-617.65%-244K
-98.78%646K
-100.52%-230K
36.40%96.86M
-100.70%-72K
-100.08%-34K
288.52%52.99M
576.72%43.97M
175.47%71.01M
110.65%10.34M
Net PPE purchase and sale
-617.65%-244K
7,288.89%647K
-102.63%-231K
78.58%-229K
35.14%-72K
92.69%-34K
97.74%-9K
-21.28%-114K
87.37%-1.07M
65.42%-111K
Net investment purchase and sale
--0
-100.00%-1K
-100.00%1K
34.70%97.09M
--0
--0
277.54%53M
568.80%44.09M
184.17%72.08M
110.80%10.45M
Cash from discontinued investing activities
Investing cash flow
-617.65%-244K
-98.78%646K
-100.52%-230K
36.40%96.86M
-100.70%-72K
-100.08%-34K
288.52%52.99M
576.72%43.97M
175.47%71.01M
110.65%10.34M
Financing cash flow
Cash flow from continuing financing activities
52,458.54%21.55M
564,825.81%175.07M
-731.25%-606K
1,717.29%53.39M
213,044.00%53.29M
-76.70%41K
-114.22%-31K
-96.19%96K
-97.49%2.94M
-99.98%25K
Net common stock issuance
18,149.55%20.26M
--0
--0
1,119.42%55.83M
370,286.67%55.53M
-71.68%111K
-115.89%-92K
-92.32%278K
-96.05%4.58M
-100.01%-15K
Proceeds from stock option exercised by employees
2,864.29%1.94M
286,891.80%175.07M
69.78%-55K
88.30%-108K
107.50%83K
67.59%-70K
116.90%61K
52.85%-182K
-179.23%-923K
-93.66%40K
Net other financing activities
---643K
--0
---551K
-224.27%-2.33M
----
----
----
----
---717K
--0
Cash from discontinued financing activities
Financing cash flow
52,458.54%21.55M
564,825.81%175.07M
-731.25%-606K
1,717.29%53.39M
213,044.00%53.29M
-76.70%41K
-114.22%-31K
-96.19%96K
-97.49%2.94M
-99.98%25K
Net cash flow
Beginning cash position
145.88%192.99M
10.73%52.46M
149.79%84.36M
-43.82%33.77M
16.38%55.21M
126.68%78.49M
5.59%47.38M
-43.82%33.77M
-50.81%60.12M
-24.99%47.44M
Current changes in cash
-39.00%-32.36M
351.68%140.53M
-334.50%-31.9M
292.02%50.59M
313.31%29.15M
-281.66%-23.28M
403.74%31.11M
189.20%13.6M
57.57%-26.35M
-337.87%-13.67M
End cash Position
190.94%160.63M
145.88%192.99M
10.73%52.46M
149.79%84.36M
149.79%84.36M
16.38%55.21M
126.68%78.49M
5.59%47.38M
-43.82%33.77M
-43.82%33.77M
Free cash flow
-131.17%-53.91M
-61.68%-35.34M
-2.35%-31.3M
1.45%-99.89M
0.01%-24.14M
17.78%-23.32M
10.79%-21.86M
-25.52%-30.58M
-8.28%-101.36M
-29.30%-24.14M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -130.46%-53.66M-61.05%-35.18M-1.97%-31.07M0.63%-99.66M-0.15%-24.06M16.54%-23.29M9.35%-21.85M-25.54%-30.47M-17.79%-100.29M-30.96%-24.03M
Net income from continuing operations -2,848.89%-812.68M-5,552.75%-1.57B-5.46%-32.49M0.81%-116.91M-16.95%-30.71M16.97%-27.56M7.14%-27.84M-8.34%-30.8M-27.98%-117.86M-9.83%-26.26M
Operating gains losses --790.46M--1.3B--1K---18K------------------------
Depreciation and amortization -99.76%2K134.41%2.04M-12.51%825K1.03%3.53M-3.03%865K-4.70%851K-0.11%869K12.66%943K38.30%3.49M41.14%892K
Other non cash items -33,846.21%-44.55M18,026.46%226.76M6.33%1.31M6.64%5.04M-50.37%2.43M105.33%132K6.20%1.25M8.17%1.23M32.11%4.73M407.05%4.89M
Change In working capital 5,208.08%5.06M228.76%4.63M35.97%-2.64M-99.23%5K461.49%2.82M-107.81%-99K68.02%1.41M-508.57%-4.12M106.61%650K-871.29%-779K
-Change in prepaid assets 55.62%-75K14,215.00%2.86M67.46%-231K-125.54%-835K-96.63%24K-149.13%-169K-99.09%20K-10,242.86%-710K1,353.33%3.27M882.42%712K
-Change in payables and accrued expense 931.13%5M98.91%1.1M44.68%-1.37M-21.37%2.24M2,043.60%3.69M-81.76%485K414.95%551K-2,720.45%-2.48M155.83%2.85M-89.61%172K
-Change in other current assets -72.60%151K10.99%1.95M300.00%14K228.72%2.43M117.77%129K167.36%551K468.13%1.76M-105.22%-7K-161.72%-1.89M-1,444.68%-726K
-Change in other current liabilities 97.93%-20K-39.17%-1.28M-13.79%-1.05M-6.89%-3.83M-9.28%-1.02M-5.34%-966K8.01%-919K-26.16%-921K65.73%-3.58M33.87%-937K
Cash from discontinued investing activities
Operating cash flow -130.46%-53.66M-61.05%-35.18M-1.97%-31.07M0.63%-99.66M-0.15%-24.06M16.54%-23.29M9.35%-21.85M-25.54%-30.47M-17.79%-100.29M-30.96%-24.03M
Investing cash flow
Cash flow from continuing investing activities -617.65%-244K-98.78%646K-100.52%-230K36.40%96.86M-100.70%-72K-100.08%-34K288.52%52.99M576.72%43.97M175.47%71.01M110.65%10.34M
Net PPE purchase and sale -617.65%-244K7,288.89%647K-102.63%-231K78.58%-229K35.14%-72K92.69%-34K97.74%-9K-21.28%-114K87.37%-1.07M65.42%-111K
Net investment purchase and sale --0-100.00%-1K-100.00%1K34.70%97.09M--0--0277.54%53M568.80%44.09M184.17%72.08M110.80%10.45M
Cash from discontinued investing activities
Investing cash flow -617.65%-244K-98.78%646K-100.52%-230K36.40%96.86M-100.70%-72K-100.08%-34K288.52%52.99M576.72%43.97M175.47%71.01M110.65%10.34M
Financing cash flow
Cash flow from continuing financing activities 52,458.54%21.55M564,825.81%175.07M-731.25%-606K1,717.29%53.39M213,044.00%53.29M-76.70%41K-114.22%-31K-96.19%96K-97.49%2.94M-99.98%25K
Net common stock issuance 18,149.55%20.26M--0--01,119.42%55.83M370,286.67%55.53M-71.68%111K-115.89%-92K-92.32%278K-96.05%4.58M-100.01%-15K
Proceeds from stock option exercised by employees 2,864.29%1.94M286,891.80%175.07M69.78%-55K88.30%-108K107.50%83K67.59%-70K116.90%61K52.85%-182K-179.23%-923K-93.66%40K
Net other financing activities ---643K--0---551K-224.27%-2.33M-------------------717K--0
Cash from discontinued financing activities
Financing cash flow 52,458.54%21.55M564,825.81%175.07M-731.25%-606K1,717.29%53.39M213,044.00%53.29M-76.70%41K-114.22%-31K-96.19%96K-97.49%2.94M-99.98%25K
Net cash flow
Beginning cash position 145.88%192.99M10.73%52.46M149.79%84.36M-43.82%33.77M16.38%55.21M126.68%78.49M5.59%47.38M-43.82%33.77M-50.81%60.12M-24.99%47.44M
Current changes in cash -39.00%-32.36M351.68%140.53M-334.50%-31.9M292.02%50.59M313.31%29.15M-281.66%-23.28M403.74%31.11M189.20%13.6M57.57%-26.35M-337.87%-13.67M
End cash Position 190.94%160.63M145.88%192.99M10.73%52.46M149.79%84.36M149.79%84.36M16.38%55.21M126.68%78.49M5.59%47.38M-43.82%33.77M-43.82%33.77M
Free cash flow -131.17%-53.91M-61.68%-35.34M-2.35%-31.3M1.45%-99.89M0.01%-24.14M17.78%-23.32M10.79%-21.86M-25.52%-30.58M-8.28%-101.36M-29.30%-24.14M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -